NCT01611428View on ClinicalTrials.gov

Absolute Bioavailability Study With Ipragliflozin

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Bioavailability of IpragliflozinHealthy Subjects
Interventions
DRUG

Ipragliflozin

Oral and Intravenous (i.v.)

Trial Locations (1)

LS2 9LH

Leeds

All Listed Sponsors
lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT01611428 - Absolute Bioavailability Study With Ipragliflozin | Biotech Hunter | Biotech Hunter